title: Lansoprazole, H. pylori, and atrophic gastritis.
authors.forename: E J
authors.initials: EJ
authors.lastname: Kuipers
authors.forename: E C
authors.initials: EC
authors.lastname: Klinkenberg-Knol
authors.forename: H P
authors.initials: HP
authors.lastname: Festen
authors.forename: S G
authors.initials: SG
authors.lastname: Meuwissen
mesh_terms: D053799:2-Pyridinylmethylsulfinylbenzimidazoles; D004791:Enzyme Inhibitors / Q000009:adverse effects*; D005757:Gastritis, Atrophic / Q000188:drug therapy / Q000382:microbiology* / Q000473:pathology*; D016481:Helicobacter Infections; D016480:Helicobacter pylori; D006801:Humans; D064747:Lansoprazole; D009853:Omeprazole / Q000009:adverse effects / Q000031:analogs & derivatives*; D054328:Proton Pump Inhibitors
chemical_list: D053799:2-Pyridinylmethylsulfinylbenzimidazoles; D004791:Enzyme Inhibitors; D054328:Proton Pump Inhibitors; D064747:Lansoprazole; D009853:Omeprazole